Serial Number 87623102
Registration 5538932
705

Registration Progress

Application Filed
Sep 26, 2017
Under Examination
Approved for Publication
May 29, 2018
Published for Opposition
May 29, 2018
Registered
Aug 14, 2018

Trademark Image

Basic Information

Serial Number
87623102
Registration Number
5538932
Filing Date
September 26, 2017
Registration Date
August 14, 2018
Published for Opposition
May 29, 2018
Drawing Code
2

Status Summary

Current Status
Active
Status Code
705
Status Date
Jan 31, 2025
Registration
Registered
Classes
005 042

Rights Holder

Replimune Limited

99
Address
69 Innovation Dr., Milton Park, Abingdon
Oxfordshire OX144RQ
GB

Ownership History

Replimune Limited

Original Applicant
99
Oxfordshire GB

Replimune Limited

Owner at Publication
99
Oxfordshire GB

Replimune Limited

Original Registrant
99
Oxfordshire GB

Legal Representation

Attorney
Melanie Howard

USPTO Deadlines

Next Deadline
957 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180814)
Due Date
August 14, 2028
Grace Period Ends
February 14, 2029

Application History

25 events
Date Code Type Description Documents
Jan 31, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jan 31, 2025 C15P O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 30, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jan 30, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 29, 2025 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Aug 1, 2024 PR23 O POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Loading...
Aug 1, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 16, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Aug 14, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 14, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 29, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 29, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 9, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 22, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 17, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 17, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 16, 2018 ALIE A ASSIGNED TO LIE Loading...
Apr 5, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 3, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 3, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 3, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 3, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 3, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 30, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 29, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders; [ pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; ] pharmaceuticals for the treatment of cancer; pharmaceuticals preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders [ ; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders ]
Class 042
[ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid ]

Additional Information

Design Mark
The mark consists of a stylized circular design with points surrounding the outer edge of the circle, within which appears the design of a triangle pointed upward.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042